Volume | 0 |
|
|||||
News | - |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Genenta Science SPA | GNTA | NASDAQ | Depository Receipt |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
2.55 |
Trades | Shares Traded | Average Volume |
---|---|---|
0 | 0 | - |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | 2.55 | USD |
Genenta Science SPA Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
46.45M | 18.22M | - | 1.19M | -7.68M | -0.42 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Genenta Science
Date | Time | Source | Heading |
---|---|---|---|
13/2/2024 | 08:05 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
08/2/2024 | 21:00 | GlobeNewswire Inc. | Genenta Demonstrated Reprogramming of the Tumor.. |
21/10/2023 | 07:15 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
06/9/2023 | 21:00 | GlobeNewswire Inc. | Genenta to Present at Upcoming Scientific and Investor.. |
28/7/2023 | 17:00 | GlobeNewswire Inc. | Genenta Announces Ongoing Clinical Trial Progress and.. |
29/6/2023 | 21:00 | GlobeNewswire Inc. | The European Commission Grants Orphan Drug Designation to.. |
16/5/2023 | 21:00 | GlobeNewswire Inc. | Genenta to Provide Update on Lead Product Temferon™ |
26/4/2023 | 21:00 | GlobeNewswire Inc. | Genenta Announces Fiscal Year 2022 Financial Results and.. |
GNTA Historical
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |